Product Information

TIROSINT 200 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.4729 per EA under NDC 71858006004. Its NADAC has been published 251 times since Dec 18, 2019.

The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIROSINT 200 MCG CAPSULE

levothyroxine sodium
$4.4729per EA
High Outlier

Strength

200 ug/1

Manufacturer

IBSA Pharma Inc.

NDC

71858006004

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

7/1/2024

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021924

On Market Since

12/1/2018

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for TIROSINT 200 MCG CAPSULE has been published 251 times since Dec 18, 2019, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.

Current price$4.4729 per EA
All-time high$4.4729 (Oct 2, 2024)
All-time low$4.1262 (Dec 18, 2019)
Median price$4.2553
Average price$4.2926
Largest weekly change+4.0% (Dec 25, 2019)
Weeks tracked251
Tracking sinceDec 18, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+4.3%

5Y

+5.2%

All

+8.4%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TIROSINT 200 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 200 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.4729 per EA (NDC 71858006004), effective Oct 2, 2024.

How has the price of TIROSINT 200 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIROSINT 200 MCG CAPSULE has risen 8.4%. It has been tracked across 251 weekly CMS publications since Dec 18, 2019.

What are the highest and lowest recorded NADAC prices for TIROSINT 200 MCG CAPSULE?

Since Dec 18, 2019, the NADAC for TIROSINT 200 MCG CAPSULE has ranged from a low of $4.1262 (Dec 18, 2019) to a high of $4.4729 (Oct 2, 2024), with a median of $4.2553 per EA.

Are there cheaper alternatives to TIROSINT 200 MCG CAPSULE?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVOTHYROXINE 200 MCG TABLET, is $0.0806 per EA — about 98% below TIROSINT 200 MCG CAPSULE.

Who manufactures TIROSINT 200 MCG CAPSULE?

TIROSINT 200 MCG CAPSULE (NDC 71858006004) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.